Impact of Anticancer Therapy on the Quality of Life of Sudanese Patients with Breast Cancer at Khartoum Oncology Hospital

This study assessed the impact of breast cancer medications on the quality of life (QOL) of 200 Sudanese patients at Khartoum Oncology Hospital. The findings indicated that 54% of patients had poor global health-QOL status, with financial difficulties and body image issues being significant concerns. Hair loss was a particularly distressing symptom, affecting 68.6% of patients' QOL. Patients on HER2-targeted or hormonal therapies reported better global health, social, emotional, and role functioning compared to those on conventional therapy. These therapies were identified as positive predictors of improved QOL, suggesting they were more beneficial for enhancing the QOL of breast cancer survivors in Sudan.